Trial Profile
Comparison of the effect of an anti-platelet approach with Ticagrelor versus placebo on asymptomatic elevations in troponin T
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders
- Focus Pharmacodynamics
- 04 May 2015 According to the Australian New Zealand Clinical Trials Registry record, status changed from not yet recruiting to discontinued.
- 04 Mar 2014 New trial record